Clinical Trials Logo

Clinical Trial Summary

The goal of this data review study is to collect data to learn more about thyroid, parathyroid, and adrenal disease.


Clinical Trial Description

If participant or participant's child agrees to take part in this study, information from the medical record will be recorded and entered into a research database at MD Anderson. Researchers will use this data to learn more about participant's or participant's child's current or suspected illness, surgery, and/or recovery as well as participant's or participant's child's medical history.

Length of Study Participant's or participant's child's active participation on this study will be over after 15 years.

Follow-Up Phone Calls Starting about 2-3 years after participant's or participant's child's testing and/or diagnosis and/or treatment and continuing for up to 15 years after participant's surgery, a member of the research team will contact participant by phone to follow up and see how participant or participant's child are doing. The first time participant receives a phone call or are asked in the clinic, participant will be asked for participant's verbal consent for participant or, if this is for participant's child, on behalf of participant's child, to speak to the member of the research team before participant or participant's child are asked any questions. After participant agrees, participant or participant's child will be asked a series of questions related to participant's or participant's child's disease (takes about 20-30 minutes) that ask about participant's or participant's child's current medical status and medical history. Each phone call should take 20-30 minutes to complete.

If participant or participant's child are scheduled for a routine clinic visit around the time of participant's or participant's child's next follow-up phone call, the research team member may talk to participant or participant's child in person at that time, or a questionnaire can be mailed to participant or participant's child if needed.

This is an investigational study.

Up to 15,000 patients will be enrolled in this study. All will be enrolled at MD Anderson. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03050762
Study type Observational
Source M.D. Anderson Cancer Center
Contact Nancy D. Perrier, MD
Phone 713-792-6940
Email NPerrier@mdanderson.org
Status Recruiting
Phase
Start date October 5, 2011
Completion date October 2027

See also
  Status Clinical Trial Phase
Completed NCT01419535 - Mifepristone Effects on Glucose Intolerance in Obese/Overweight Adults Phase 1/Phase 2
Completed NCT00001849 - New Imaging Techniques in the Evaluation of Patients With Ectopic Cushing Syndrome Phase 2
Terminated NCT00001850 - Evaluation of Women With Endocrine and Reproductive-Related Conditions
Recruiting NCT03867448 - Study of Endocrine-Related Conditions and Physiology
Recruiting NCT00004847 - Diagnosis of Pheochromocytoma Phase 1
Active, not recruiting NCT03014882 - Sperm DNA Damage in β-thalassemia Major: Is There a Role for Antioxidants? Phase 1/Phase 2
Completed NCT01735617 - Pilot Study to Characterize and Examine the Pharmacokinetics and Efficacy of Chronocort® in Adults With CAH Phase 2
Recruiting NCT01511588 - Hormonal Regulation of Puberty and Fertility